1110 related articles for article (PubMed ID: 30767754)
41. A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).
Ramu V; Gill MR; Jarman PJ; Turton D; Thomas JA; Das A; Smythe C
Chemistry; 2015 Jun; 21(25):9185-97. PubMed ID: 25950156
[TBL] [Abstract][Full Text] [Related]
42. Appended Aromatic Moieties Determine the Cytotoxicity of Neutral Cyclometalated Platinum(II) Complexes Derived from 2-(2-Pyridyl)benzimidazole.
Vaquero M; Busto N; Fernández-Pampín N; Espino G; García B
Inorg Chem; 2020 Apr; 59(7):4961-4971. PubMed ID: 32182052
[TBL] [Abstract][Full Text] [Related]
43. Novel cis-[(NHC)
Rehm T; Rothemund M; Muenzner JK; Noor A; Kempe R; Schobert R
Dalton Trans; 2016 Oct; 45(39):15390-15398. PubMed ID: 27603959
[TBL] [Abstract][Full Text] [Related]
44. A Potential Bone-Targeting Hypotoxic Platinum(II) Complex with an Unusual Cytostatic Mechanism toward Osteosarcoma Cells.
Zhang Z; Zhu Z; Luo C; Zhu C; Zhang C; Guo Z; Wang X
Inorg Chem; 2018 Mar; 57(6):3315-3322. PubMed ID: 29513007
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, physicochemical and in vitro pharmacological investigation of new platinum (II) complexes with some cycloalkanespiro-5'-hydantoins.
Bakalova A; Buyukliev R; Momekov G; Ivanov D; Todorov D; Konstantinov S; Karaivanova M
Eur J Med Chem; 2005 Jun; 40(6):590-6. PubMed ID: 15922842
[TBL] [Abstract][Full Text] [Related]
46. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
Komeda S
Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
[TBL] [Abstract][Full Text] [Related]
47. Crystal structures, spectroscopic properties of new cobalt(II), nickel(II), zinc(II) and palladium(II) complexes derived from 2-acetyl-5-chloro thiophene thiosemicarbazone: Anticancer evaluation.
Şen B; Kalhan HK; Demir V; Güler EE; Kayalı HA; Subaşı E
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():550-559. PubMed ID: 30813058
[TBL] [Abstract][Full Text] [Related]
48. Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives.
Serratrice M; Maiore L; Zucca A; Stoccoro S; Landini I; Mini E; Massai L; Ferraro G; Merlino A; Messori L; Cinellu MA
Dalton Trans; 2016 Jan; 45(2):579-90. PubMed ID: 26609781
[TBL] [Abstract][Full Text] [Related]
49. Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl amines.
Anderson WK; Kasliwal R; Houston DM; Wang YS; Narayanan VL; Haugwitz RD; Plowman J
J Med Chem; 1995 Sep; 38(19):3789-97. PubMed ID: 7562909
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and cytotoxicity of platinum(II) complexes of 3-aminocyclopentanespiro-5-hydantoin and 3-aminocycloheptanespiro-5-hydantoin.
Kushev D; Naydenova E; Popova J; Maneva L; Grancharov K; Spassovska N
Z Naturforsch C J Biosci; 2003; 58(1-2):103-8. PubMed ID: 12622235
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of anticancer activity of novel platinum(II) bis(thiosemicarbazone) complex against breast cancer.
Radomska D; Szewczyk-Roszczenko OK; Marciniec K; Książek M; Kusz J; Roszczenko P; Szymanowska A; Radomski D; Bielawski K; Czarnomysy R
Bioorg Chem; 2024 Jul; 148():107486. PubMed ID: 38788367
[TBL] [Abstract][Full Text] [Related]
52. A monofunctional platinum(II)-based anticancer agent from a salicylanilide derivative: Synthesis, antiproliferative activity, and transcription inhibition.
Wang B; Wang Z; Ai F; Tang WK; Zhu G
J Inorg Biochem; 2015 Jan; 142():118-25. PubMed ID: 25450026
[TBL] [Abstract][Full Text] [Related]
53. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
[TBL] [Abstract][Full Text] [Related]
54. Pd
Amatori S; Ambrosi G; Errico Provenzano A; Fanelli M; Formica M; Fusi V; Giorgi L; Macedi E; Micheloni M; Paoli P; Rossi P
J Inorg Biochem; 2016 Sep; 162():154-161. PubMed ID: 27389827
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, Anticancer Evaluation and Synergistic Effects with cisplatin of Novel Palladium Complexes: DNA, BSA Interactions and Molecular Docking Study.
Joksimović N; Janković N; Petronijević J; Baskić D; Popovic S; Todorović D; Zarić M; Klisurić O; Vraneš M; Tot A; Bugarčić Z
Med Chem; 2020; 16(1):78-92. PubMed ID: 30686264
[TBL] [Abstract][Full Text] [Related]
56. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.
Margiotta N; Natile G; Capitelli F; Fanizzi FP; Boccarelli A; De Rinaldis P; Giordano D; Coluccia M
J Inorg Biochem; 2006 Nov; 100(11):1849-57. PubMed ID: 16959321
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
[TBL] [Abstract][Full Text] [Related]
58. New bio-sensitive and biologically active single crystal of pyrimidine scaffold ligand and its gold and platinum complexes: DFT, antimicrobial, antioxidant, DNA interaction, molecular docking with DNA/BSA and anticancer studies.
Sankarganesh M; Dhaveethu Raja J; Sakthikumar K; Solomon RV; Rajesh J; Athimoolam S; Vijayakumar V
Bioorg Chem; 2018 Dec; 81():144-156. PubMed ID: 30121002
[TBL] [Abstract][Full Text] [Related]
59. Novel dinuclear platinum(II) complexes containing mixed nitrogen-sulfur donor ligands.
Hochreuther S; Puchta R; van Eldik R
Inorg Chem; 2011 Dec; 50(24):12747-61. PubMed ID: 22085155
[TBL] [Abstract][Full Text] [Related]
60. Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs.
Piccinonna S; Margiotta N; Pacifico C; Lopalco A; Denora N; Fedi S; Corsini M; Natile G
Dalton Trans; 2012 Aug; 41(32):9689-99. PubMed ID: 22782180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
